HER
HER inhibitors are compounds that block the activity of Human Epidermal Growth Factor Receptors, particularly HER2, which is overexpressed in certain breast cancers and other malignancies. Inhibition of HER signaling pathways is a key strategy in targeted cancer therapies. At CymitQuimica, we offer HER inhibitors to support your research in oncology, targeted therapies, and cell signaling.
Found 12 products for "HER".
Filter by
Purity percentage
0
100
|
0
|
50
|
90
|
95
|
100
- Lower prices
- Higher prices
- Lower purities
- Higher purities
- Faster estimated delivery
Coprelotamab
CAS:Coprelotamab is a humanized mAb targeting HER2 that inhibits tumor growth by blocking receptor dimerization and mediating ADCC, used for HER2-positive cancer research.Purity:95%Color and Shape:Transparent LiquidTrastuzumab-anns
CAS:Trastuzumab-anns is a biosimilar of Herceptin and a monoclonal antibody targeting HER2 that is used for HER2-positive breast cancer and gastric cancer.Purity:95%Color and Shape:LiquidMolecular weight:~150 kDaHER2/neu (654-662) GP2 acetate
GP2 acetate, from HER2 (654-662), triggers HLA-A2-restricted T cells to attack epithelial cancers.Formula:C44H81N9O13Purity:98%Color and Shape:SolidMolecular weight:944.17Panomifene HCl
CAS:Panomifene HCl is a selective anti-estrogenic compound with antitumor activity for the treatment of breast cancer.Formula:C25H25ClF3NO2Purity:99.53%Color and Shape:SolidMolecular weight:463.92PF04929113
CAS:PF04929113 (SNX-5422), a synthetic small molecule Hsp90 inhibitor, offers potent efficacy orally for various cancers.Formula:C25H30F3N5O4Purity:99.04%Color and Shape:SolidMolecular weight:521.532PF-04929113 Mesylate
CAS:PF-04929113 Mesylate (SNX-5422 Mesylate), a prodrug of SNX-2112, is an orally available Hsp90 inhibitor (Kd: 41 nM) and also induces Her-2 degradation (IC50: 37Formula:C26H34F3N5O7SPurity:99% - 99.46%Color and Shape:SolidMolecular weight:617.638BMS 599626 2HCl
CAS:BMS 599626 2HCl (873837-23-1(HCl)) (AC480 dihydrochloride) is a selective inhibitor of HER1 and HER2 (IC50s: 20 nM and 30 nM), ~8-fold less potent to HER4, >100Formula:C27H29FN8O3Cl2Purity:99.94%Color and Shape:SoildMolecular weight:603.48Runimotamab
CAS:Runimotamab is a T-cell-engaging bispecific antibody targeting HER2 and CD3 that promotes T-cell-mediated killing of HER2-expressing tumor cells for research on HER2-expressing cancers and tumor spheroid models.Purity:99%Color and Shape:Odour LiquidAnbenitamab
CAS:Anbenitamab (KN-026) is a HER2 biparatopic bispecific antibody that exerts potent anti-tumor efficacy by inhibiting HER2 signaling and mediating ADCC.Color and Shape:LiquidCinrebafusp alfa
CAS:Cinrebafusp alfa is a CD137/HER2 bispecific antibody mediating T cell co-stimulation, with potential in HER2-positive solid tumor research.Purity:95%Color and Shape:LiquidNezutatug
CAS:Nezutatug is a humanized monoclonal antibody targeting HER3 which inhibits receptor dimerization and tumor-cell growth for research on HER3 signaling and tumor biology.Purity:95%Color and Shape:LiquidHER2-IN-12
CAS:HER2-IN-12 is a selective HER2 inhibitor; blocks autophosphorylation; inhibits signaling; breast cancer research.Formula:C17H18BrN5O2SColor and Shape:SolidMolecular weight:436.33
